Bristol-Myers Squibb Company Ce

CELG-RINYSEHealthcare● Active

$0.11

+$0.01(+10.23%)

Market Cap$224423493

P/E Ratio—

52W High$0.123

52W Low$0.0998

Avg Volume38K

Open$0.12

Beta-0.54

Overview

Bristol-Myers Squibb Company Ce（CELG-RI）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · CELG-RI · 截至 2026年6月10日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

中性

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Bristol-Myers Squibb Company Ce内部人在过去近12个月买卖活动混合。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月10日

近期内幕交易记录

CELG-RI 高管卖出股份 · CELG-RI 董事内幕交易 · SEC Form 4申报

显示最近 18 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Nov 20, 2019	VESSEY RUPERT PRES., RESEARCH AND EARLY DEV.	Award	24,209	—	—	60,927	Form 4
Nov 20, 2019	VESSEY RUPERT PRES., RESEARCH AND EARLY DEV.	Award	13,906	—	—	36,718	Form 4
Nov 20, 2019	VESSEY RUPERT PRES., RESEARCH AND EARLY DEV.	Award	8,634	—	—	22,812	Form 4
Nov 20, 2019	VESSEY RUPERT PRES., RESEARCH AND EARLY DEV.	Other	613	—	—	0	Form 4
Nov 20, 2019	AHMED NADIM PRES., GLOBAL HEM. AND ONC.	Award	17,840	—	—	40,694	Form 4
Nov 20, 2019	AHMED NADIM PRES., GLOBAL HEM. AND ONC.	Award	8,035	—	—	22,854	Form 4
Nov 20, 2019	AHMED NADIM PRES., GLOBAL HEM. AND ONC.	Other	1,966	—	—	0	Form 4
Nov 20, 2019	Alles Mark J CEO, CHAIRMAN OF BOARD · Director	Award	74,414	—	—	366,495	Form 4
Nov 20, 2019	Alles Mark J CEO, CHAIRMAN OF BOARD · Director	Award	45,119	—	—	292,081	Form 4
Nov 20, 2019	Alles Mark J CEO, CHAIRMAN OF BOARD · Director	Award	25,696	—	—	246,962	Form 4
Nov 20, 2019	Alles Mark J CEO, CHAIRMAN OF BOARD · Director	Other	6,252	—	—	0	Form 4
Nov 20, 2019	Elkins David V EVP, CHIEF FINANCIAL OFFICER	Award	25,484	—	—	57,132	Form 4
Nov 20, 2019	Elkins David V EVP, CHIEF FINANCIAL OFFICER	Award	11,088	—	—	31,648	Form 4
Nov 20, 2019	Elkins David V EVP, CHIEF FINANCIAL OFFICER	Award	6,652	—	—	20,560	Form 4
Nov 20, 2019	Elkins David V EVP, CHIEF FINANCIAL OFFICER	Other	195	—	—	0	Form 4
Nov 20, 2019	Curran Terrie PRES., GLBL INFLAM. AND IMMUN.	Award	17,840	—	—	37,181	Form 4
Nov 20, 2019	Curran Terrie PRES., GLBL INFLAM. AND IMMUN.	Award	9,889	—	—	19,341	Form 4
Nov 20, 2019	Curran Terrie PRES., GLBL INFLAM. AND IMMUN.	Award	5,139	—	—	9,452	Form 4

VESSEY RUPERT

PRES., RESEARCH AND EARLY DEV.

Award

日期

Nov 20

股数

24,209

均价

—

总金额

—

View Form 4 on SEC.gov

VESSEY RUPERT

PRES., RESEARCH AND EARLY DEV.

Award

日期

Nov 20

股数

13,906

均价

—

总金额

—

View Form 4 on SEC.gov

VESSEY RUPERT

PRES., RESEARCH AND EARLY DEV.

Award

日期

Nov 20

股数

8,634

均价

—

总金额

—

View Form 4 on SEC.gov

VESSEY RUPERT

PRES., RESEARCH AND EARLY DEV.

Other

日期

Nov 20

股数

613

均价

—

总金额

—

View Form 4 on SEC.gov

AHMED NADIM

PRES., GLOBAL HEM. AND ONC.

Award

日期

Nov 20

股数

17,840

均价

—

总金额

—

View Form 4 on SEC.gov

AHMED NADIM

PRES., GLOBAL HEM. AND ONC.

Award

日期

Nov 20

股数

8,035

均价

—

总金额

—

View Form 4 on SEC.gov

AHMED NADIM

PRES., GLOBAL HEM. AND ONC.

Other

日期

Nov 20

股数

1,966

均价

—

总金额

—

View Form 4 on SEC.gov

Alles Mark J

CEO, CHAIRMAN OF BOARD · Director

Award

日期

Nov 20

股数

74,414

均价

—

总金额

—

View Form 4 on SEC.gov

Alles Mark J

CEO, CHAIRMAN OF BOARD · Director

Award

日期

Nov 20

股数

45,119

均价

—

总金额

—

View Form 4 on SEC.gov

Alles Mark J

CEO, CHAIRMAN OF BOARD · Director

Award

日期

Nov 20

股数

25,696

均价

—

总金额

—

View Form 4 on SEC.gov

Alles Mark J

CEO, CHAIRMAN OF BOARD · Director

Other

日期

Nov 20

股数

6,252

均价

—

总金额

—

View Form 4 on SEC.gov

Elkins David V

EVP, CHIEF FINANCIAL OFFICER

Award

日期

Nov 20

股数

25,484

均价

—

总金额

—

View Form 4 on SEC.gov

Elkins David V

EVP, CHIEF FINANCIAL OFFICER

Award

日期

Nov 20

股数

11,088

均价

—

总金额

—

View Form 4 on SEC.gov

Elkins David V

EVP, CHIEF FINANCIAL OFFICER

Award

日期

Nov 20

股数

6,652

均价

—

总金额

—

View Form 4 on SEC.gov

Elkins David V

EVP, CHIEF FINANCIAL OFFICER

Other

日期

Nov 20

股数

195

均价

—

总金额

—

View Form 4 on SEC.gov

Curran Terrie

PRES., GLBL INFLAM. AND IMMUN.

Award

日期

Nov 20

股数

17,840

均价

—

总金额

—

View Form 4 on SEC.gov

Curran Terrie

PRES., GLBL INFLAM. AND IMMUN.

Award

日期

Nov 20

股数

9,889

均价

—

总金额

—

View Form 4 on SEC.gov

Curran Terrie

PRES., GLBL INFLAM. AND IMMUN.

Award

日期

Nov 20

股数

5,139

均价

—

总金额

—

View Form 4 on SEC.gov

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 CELG-RI 内幕交易

CELG-RI 内幕交易

Bristol-Myers Squibb Company Ce（CELG-RI）内幕交易数据来源于公司内部人（包括CELG-RI）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。CELG-RI内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Bristol-Myers Squibb Company Ce机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

CELG-RI 内幕交易 · 5个问题

Bristol-Myers Squibb Company Ce（CELG-RI）的内部人包括高管和董事，如CELG-RI等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

CELG-RI 董事内幕交易CELG-RI 内部人名单Bristol-Myers Squibb Company Ce 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 10, 2026